Literature DB >> 2994387

Squamous cell carcinoma of the nasopharynx. An analysis of failure patterns after radiation therapy.

S Yamashita, M Kondo, S Hashimoto.   

Abstract

Seventy-seven patients with nasopharyngeal squamous cell carcinoma were treated with irradiation, with or without chemotherapy. Sixty-three (82%) developed a relapse in some part of the body; the first relapse appeared at primary, cervical and distant sites in 45 (71%), 30 (48%) and 12 (19%) of the 63 relapsing patients, respectively. In 22 of the 63 relapsing patients, the first relapse occurred simultaneously in two or more sites. Local recurrence-free survival was higher for the T1 + T2 group than for the T3 + T4 group (p less than 0.02). Cervical relapse-free survival was higher for N0 patients than for N+ patients (p less than 0.02). Distant metastases frequently developed as a component of the first relapse. Distant metastases were more common in N+ patients than in N0 patients. Forty-two patients received adjuvant chemotherapy. Although local recurrence-free survival tended to be higher in patients with chemotherapy than without chemotherapy, survival rates and relapse-free survival rates did not differ in the two groups.

Entities:  

Mesh:

Year:  1985        PMID: 2994387     DOI: 10.3109/02841868509136058

Source DB:  PubMed          Journal:  Acta Radiol Oncol        ISSN: 0349-652X


  13 in total

1.  An orthotopic model of metastatic nasopharyngeal carcinoma and its application in elucidating a therapeutic target that inhibits metastasis.

Authors:  Pamela A Smith; David Merritt; Leah Barr; David A Thorley-Lawson
Journal:  Genes Cancer       Date:  2011-11

Review 2.  Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.

Authors:  Josephine Chou; Yu-Ching Lin; Jae Kim; Liang You; Zhidong Xu; Biao He; David M Jablons
Journal:  Head Neck       Date:  2008-07       Impact factor: 3.147

3.  H3K27me3 protein is a promising predictive biomarker of patients' survival and chemoradioresistance in human nasopharyngeal carcinoma.

Authors:  Mu-Yan Cai; Zhu-Ting Tong; Wei Zhu; Zhu-Zhi Wen; Hui-Lan Rao; Ling-Ling Kong; Xin-Yuan Guan; Hsiang-Fu Kung; Yi-Xin Zeng; Dan Xie
Journal:  Mol Med       Date:  2011-07-05       Impact factor: 6.354

4.  Zoledronic acid augments the radiosensitivity of cancer cells through perturbing S- and M-phase cyclins and p21CIP1 expression.

Authors:  Chi Du; Yuyi Wang; Haijun Li; Yi Huang; Ou Jiang; Yanjie You; Feng Luo
Journal:  Oncol Lett       Date:  2017-08-03       Impact factor: 2.967

5.  Overexpression of Nogo receptor 3 (NgR3) correlates with poor prognosis and contributes to the migration of epithelial cells of nasopharyngeal carcinoma patients.

Authors:  Jiang-Yi He; Ping Han; Yu Zhang; Yong-Dong Liu; Shi-Jian Song; Guo-Kai Feng; Yu An; Ai-Jun Zhou; Hong-Bo Wang; Li Yuan; Zhi-Rui Lin; Tian-Liang Xia; Man-Zhi Li; Yan-Min Liu; Xiao-Ming Huang; Hua Zhang; Qian Zhong
Journal:  J Mol Med (Berl)       Date:  2018-01-11       Impact factor: 4.599

Review 6.  Contribution of radiotherapy to function preservation and cancer outcome in primary treatment of nasopharyngeal carcinoma.

Authors:  Anne W M Lee
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

7.  Aberrant activation of hedgehog pathway in nasopharyngeal carcinoma.

Authors:  Yongjian Yue; Weide Zhong; Genwang Pei; Baiyu Xiao; Guoping Zhang; Funeng Jiang; Jinglin Zhang; Changhua Chen; Peizhou Yang; Hua Dang; Hong Chang
Journal:  Clin Exp Med       Date:  2012-07-20       Impact factor: 3.984

8.  A five-variable signature predicts radioresistance and prognosis in nasopharyngeal carcinoma patients receiving radical radiotherapy.

Authors:  Hong-Mei Yi; Hong Yi; Jin-Feng Zhu; Ta Xiao; Shan-Shan Lu; Yong-Jun Guan; Zhi-Qiang Xiao
Journal:  Tumour Biol       Date:  2015-09-27

9.  Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinoma.

Authors:  Jing-Yan Cao; Li Liu; Shu-Peng Chen; Xing Zhang; Yan-Jun Mi; Zhi-Gang Liu; Man-Zhi Li; Hua Zhang; Chao-Nan Qian; Jian-Yong Shao; Li-Wu Fu; Yun-Fei Xia; Mu-Sheng Zeng
Journal:  Mol Cancer       Date:  2010-09-09       Impact factor: 27.401

10.  ULK1: a promising biomarker in predicting poor prognosis and therapeutic response in human nasopharygeal carcinoma.

Authors:  Miao Yun; Hai-Yan Bai; Jia-Xing Zhang; Jian Rong; Hui-Wen Weng; Zhou-San Zheng; Yi Xu; Zhu-Ting Tong; Xiao-Xia Huang; Yi-Ji Liao; Shi-Juan Mai; Sheng Ye; Dan Xie
Journal:  PLoS One       Date:  2015-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.